Table 3b

Detection rate of adenoma, advanced adenoma, CRC and positive predictive value for advanced neoplasia (advanced adenoma+CRC)

Programmes using faecal tests
Age 50–75 years
gFOBT programmes	Screenees	Adenomas		Advanced adenomas		CRC		PPV AN
gFOBT programmes	N	N	%	N	%	N	‰	%
Belgium Wallonia+Brussels, women	21.570	197	0.9	71	0.3	36	1.7	18.6
Belgium Wallonia+Brussels, men	19.049	263	1.4	117	0.6	43	2.3	26.4
Belgium Wallonia+Brussels, all	40.619	460	1.1	188	0.5	79	1.9	22.6
Croatia, all	202.951	2.160	1.1	NA		328	1.6	4.9
Finland, women	33.316	145	0.4	24	0.1	19	0.6	7.4
Finland, men	25.934	270	1.0	32	0.1	34	1.3	8.2
Finland, all	59.250	415	0.7	56	0.1	53	0.9	7.9
France, women	1.273.503	5.413	0.4	3.023	0.2	906	0.7	18.8
France, men	1.042.750	9.151	0.9	5.540	0.5	1.542	1.5	31.6
France, all	2.316.253	14.564	0.6	8.563	0.4	2.448	1.1	25.4
Sweden Stockholm Gotland, women	36.491	173	0.5	52	0.1	29	0.8	8.7
Sweden Stockholm Gotland, men	28.571	317	1.1	122	0.4	38	1.3	14.2
Sweden Stockholm Gotland, all	65.062	490	0.8	174	0.3	67	1.0	11.7
UK England, women	1.150.602	4.371	0.4	887	0.1	977	0.8	13.4
UK England, men	1.020.427	7.292	0.7	2.433	0.2	1.874	1.8	22.4
UK England, all	2.171.029	11.663	0.5	3.320	0.2	2.851	1.3	18.6
UK Northern Ireland, all	62 970	597	0.9	NA		103	1.6	8.1
UK Scotland, women	261.227	1.010	0.4	83	0.0	224	0.9	9.1
UK Scotland, men	230.304	2.048	0.9	322	0.1	336	1.5	13.9
UK Scotland, all	491.531	3.058	0.6	405	0.1	560	1.1	11.9
UK Wales, women	72.380	180	0.2	NA	0.0	64	0.9	6.7
UK Wales, all	63.388	385	0.6	NA	0.0	131	2.1	8.6
UK Wales, all	135.768	565	0.4	NA	0.0	195	1.4	7.9